Back to Trades
Zikria Dean
Interim CEODirectorCIK 0001877611
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, Zikria Dean, Interim CEO, Director, has disclosed $24.9K in transactions — all concentrated in Valion Bio, Inc. (VBIO). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Sep 24 | VBIO Valion Bio, Inc. | Zikria Dean | Interim CEO, Director | Award | $0 |
| Aug 8 | TIVC Tivic Health Systems, Inc. | Zikria Dean | Director | Award | $24.9K |
2 filings